Inventor · disambiguated record
Laurence Clary
Also filed as: CLARY LAURENCE
37 granted patents·3 pending applications·141 citations·filing 2002–2020
96Inventor score
Top patents by PatentIndex Score
40 records- 0194US6908939B2Biaromatic ligand activators of PPARγ receptorsGALDERMA RES & DEV·Filed 2002·Granted Jun 21, 2005·38 cites·17 claims
- 0292US7294639B2Biaromatic ligand activators of PPARγ receptorsGALDERMA RES & DEV·Filed 2006·Granted Nov 13, 2007·7 cites·16 claims
- 0389US7122564B2Biaromatic ligand activators of PPARγ receptorsGALDERMA RES & DEV·Filed 2005·Granted Oct 17, 2006·5 cites·18 claims
- 0487US6927228B2Biaromatic compound activators of PPARγ-type receptorsGALDERMA RES & DEV·Filed 2003·Granted Aug 9, 2005·46 cites·14 claims
- 0582US8633196B2Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmeticsGALDERMA RES & DEV·Filed 2013·Granted Jan 21, 2014·4 cites·16 claims
- 0682US7625914B2Compounds that modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Granted Dec 1, 2009·5 cites·38 claims
- 0780US8513297B2Biaromatic compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereofBOITEAU JEAN-GUY·Filed 2012·Granted Aug 20, 2013·5 cites·27 claims
- 0880US8420632B2Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmeticsCLARY LAURENCE·Filed 2010·Granted Apr 16, 2013·5 cites·21 claims
- 0980US7125869B2Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Granted Oct 24, 2006·4 cites·81 claims
- 1079US8980897B2Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmeticsGALDERMA RES & DEV·Filed 2013·Granted Mar 17, 2015·3 cites·27 claims
- 1178US7307078B2Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2006·Granted Dec 11, 2007·3 cites·81 claims
- 1278US7285568B2Biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Granted Oct 23, 2007·4 cites·14 claims
- 1376US9090596B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologiesGALDERMA RES & DEV·Filed 2012·Granted Jul 28, 2015·3 cites·9 claims
- 1476US7863332B2Biaromatic compound activators of PPARγ receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2007·Granted Jan 4, 2011·2 cites·50 claims
- 1575US7452878B2Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Granted Nov 18, 2008·2 cites·15 claims
- 1670US9580412B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2016·Granted Feb 28, 2017·1 cites·11 claims
- 1768US9526732B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologiesGALDERMA RES & DEV·Filed 2015·Granted Dec 27, 2016·1 cites·8 claims
- 1868US8772478B2Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmeticsCLARY LAURENCE·Filed 2010·Granted Jul 8, 2014·2 cites·20 claims
- 1967US9388149B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2012·Granted Jul 12, 2016·1 cites·10 claims
- 2065US8022079B2Methods of modulating PPAR gamma-type receptorsGALDERMA RES & DEV·Filed 2009·Granted Sep 20, 2011·0 cites·34 claims
- 2165US7968560B2Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compoundsGALDERMA RES & DEV·Filed 2009·Granted Jun 28, 2011·0 cites·31 claims
- 2261US7973063B2Methods for activating PPAR gamma-type receptorsGALDERMA RES & DEV·Filed 2009·Granted Jul 5, 2011·0 cites·37 claims
- 2359US7807669B2Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2008·Granted Oct 5, 2010·0 cites·16 claims
- 2457US8129416B2Biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereofBOITEAU JEAN-GUY·Filed 2007·Granted Mar 6, 2012·0 cites·27 claims
- 2556US7626054B2Biaromatic compounds which activate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2006·Granted Dec 1, 2009·0 cites·56 claims
- 2655US2016280650A1Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmeticsGALDERMA RES & DEV·Filed 2016·Application pending·0 cites
- 2754US9365529B2Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmeticsGALDERMA RES & DEV·Filed 2015·Granted Jun 14, 2016·0 cites·17 claims
- 2854US8404836B23-phenyl acrylic acid compound activators of type PPAR receptors and pharmaceutical/cosmetic compositions comprised thereofBOITEAU JEAN-GUY·Filed 2009·Granted Mar 26, 2013·0 cites·44 claims
- 2954US2013303549A1Novel biaromatic compounds that modulate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2013·Application pending·0 cites
- 3052US11518767B2MTOR inhibitor compoundsGALDERMA RES & DEV·Filed 2020·Granted Dec 6, 2022·0 cites·10 claims
- 3151US11731973B2Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitorsGALDERMA RES & DEV·Filed 2020·Granted Aug 22, 2023·0 cites·17 claims
- 3251US7879907B23-phenylpropanoic compound activators of receptors of PPAR type and pharmaceutical/cosmetic compositions comprised thereofGALDERMA RES & DEV·Filed 2009·Granted Feb 1, 2011·0 cites·23 claims
- 3350US8383652B2Biaromatic compounds that modulate PPAR-receptorsGALDERMA RES & DEV·Filed 2008·Granted Feb 26, 2013·0 cites·34 claims
- 3449US9120772B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2012·Granted Sep 1, 2015·0 cites·6 claims
- 3547US7582663B2Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2007·Granted Sep 1, 2009·0 cites·18 claims
- 3647US2007207175A1Biaromatic compound activators of PPARgamma receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2007·Application pending·0 cites
- 3742US9415039B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2015·Granted Aug 16, 2016·0 cites·8 claims
- 3836US9266848B24-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseasesCLARY LAURENCE·Filed 2010·Granted Feb 23, 2016·0 cites·20 claims
- 3935US10246422B2Heterocyclic compounds and use thereof in medicine and in cosmeticsGALDERMA RES & DEV·Filed 2015·Granted Apr 2, 2019·0 cites·18 claims
- 4027US9115102B2N-[2-hydroxycarbamoyl-2-(piperazinyl) ethyl] benzamide compounds, their preparation and their use as TACE inhibitorsCHAMBON SANDRINE·Filed 2010·Granted Aug 25, 2015·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Laurence Clary files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →